d4a5a598c2410dddc7dbc546b392f291

Events Search and Views Navigation

Event Views Navigation

Today

Filters

Changing any of the form inputs will cause the list of events to refresh with the filtered results.

Annual Alumni Dinner Honoring Mark Borchert, MD

Doheny Eye Institute 150 North Orange Grove Blvd. Rm 264, Pasadena, CA, United States

All friends, colleagues, family, and alumni are invited to celebrate this year’s honoree, Mark S. Borchert, MD, of CHLA. Each year the Doheny Professional Association honors a member as the “Distinguished Alumnus” for achievement and commitment to the advancement of ophthalmic research, education, or patient care. The annual dinner is immediately following the conference. RSVPs can be made at doheny.org/alumni23.

Distinguished Lecture Series – Maya Koronyo-Hamaoui, PhD

Doheny Eye Institute 150 North Orange Grove Blvd. Rm 264, Pasadena, CA, United States

Dr. Maya Koronyo-Hamaoui is Professor of Neurosurgery and Professor of Biomedical Sciences at Cedars-Sinai, Los Angeles. Her primary research focus is on early diagnosis and immune-based therapies for Alzheimer's disease (AD). The Koronyo-Hamaoui Laboratory has shown that the hallmark pathology of AD, amyloid-β protein (Aβ) plaque, is present in the retina of human patients beginning at early stages. A unique approach has been developed in her lab to detect plaques in the retina of live rodent models by a noninvasive optical retinal imaging. This innovation unveils new possibilities for investigation of Alzheimer's pathology in the retina. It may also facilitate early diagnosis and noninvasive monitoring of disease progression.

Distinguished Lecture Series – Alzheimer’s Disease Landscape in The Retina

Doheny Eye Institute 150 North Orange Grove Blvd. Rm 264, Pasadena, CA, United States

Dr. Maya Koronyo-Hamaoui is Professor of Neurosurgery and Professor of Biomedical Sciences at Cedars-Sinai, Los Angeles. Her primary research focus is on early diagnosis and immune-based therapies for Alzheimer's disease (AD). The Koronyo-Hamaoui Laboratory has shown that the hallmark pathology of AD, amyloid-β protein (Aβ) plaque, is present in the retina of human patients beginning at early stages. A unique approach has been developed in her lab to detect plaques in the retina of live rodent models by a noninvasive optical retinal imaging. This innovation unveils new possibilities for investigation of Alzheimer's pathology in the retina. It may also facilitate early diagnosis and noninvasive monitoring of disease progression.